Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Oncogene|February 26, 2013
NF-κB is a critical mediator of BRCA1-induced chemoresistanceMary T Harte, Julia J Gorski, Kienan I Savage, et al.
The Biochemical Journal|October 14, 2022
Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potentialSuzanne Madgwick, Saimir Luli, Helene Sellier, et al.
The Biochemical Journal|October 14, 2022
Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cellsJill E Hunter, Amy E Campbell, Scott Kerridge, et al.
Hepatology (Baltimore, Md.)|September 22, 2012
Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune responseAnna Moles, Ana M Sanchez, Paul S Banks, et al.
The Journal of Biological Chemistry|June 14, 2005
Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanismMaofu Fu, Chenguang Wang, Mahadev Rao, et al.
Molecular Cell|December 13, 2006
SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genesMakiko Fujii, Lyudmila A Lyakh, Cameron P Bracken, et al.
Molecular Cancer Therapeutics|October 11, 2018
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial CarcinomaSumati Gupta, Daniel J Albertson, Timothy J Parnell, et al.
Hepatology (Baltimore, Md.)|September 11, 2022
c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesisJack Leslie, Jill E Hunter, Amy Collins, et al.
Pageof 9